Heinz Feldmann
#102,514
Most Influential Person Now
German-American virologist
Heinz Feldmann's AcademicInfluence.com Rankings
Heinz Feldmannbiology Degrees
Biology
#5430
World Rank
#7908
Historical Rank
Virology
#111
World Rank
#115
Historical Rank
Download Badge
Biology
Heinz Feldmann's Degrees
- PhD Virology University of Marburg
- Doctorate Medicine University of Marburg
Why Is Heinz Feldmann Influential?
(Suggest an Edit or Addition)According to Wikipedia, Heinz Ulrich Feldmann is a German-American virologist who currently serves as the chief of the laboratory of virology at Rocky Mountain Laboratories, NIAID and heads the Disease Modelling and Transmission section. His research focuses on highly pathogenic viruses that require strict biocontainment, including those that cause viral hemorrhagic fever such as Ebola and Lassa. He has been responsible for the development of timely viral countermeasures including the rVSV-ZEBOV vaccine , development of vaccines and drugs against SARS-CoV-2, and epidemiology of SARS-CoV.
Heinz Feldmann's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Genome Sequence of the SARS-Associated Coronavirus (2003) (2063)
- Ebola haemorrhagic fever (2011) (1211)
- Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. (1993) (1038)
- Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus (2007) (939)
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection (2020) (789)
- Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses (2005) (626)
- Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus (2004) (492)
- Processing of the Ebola virus glycoprotein by the proprotein convertase furin. (1998) (469)
- Person-to-Person Transmission of Nipah Virus in a Bangladeshi Community (2007) (398)
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques (2013) (397)
- Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. (1999) (372)
- Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses (2004) (321)
- Panmicrobial Oligonucleotide Array for Diagnosis of Infectious Diseases (2007) (309)
- Marburg and Ebola viruses. (1996) (299)
- Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques (2013) (289)
- Effective Post-Exposure Treatment of Ebola Infection (2007) (287)
- Ebola virus: from discovery to vaccine (2003) (278)
- Tyro3 Family-Mediated Cell Entry of Ebola and Marburg Viruses (2006) (268)
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin (2013) (265)
- Human Macrophage C-Type Lectin Specific for Galactose and N-Acetylgalactosamine Promotes Filovirus Entry (2004) (255)
- Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein (1996) (253)
- Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages (1996) (251)
- Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance (2014) (249)
- Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus (2009) (244)
- Development of a New Vaccine for the Prevention of Lassa Fever (2005) (237)
- Infection and Activation of Monocytes by Marburg and Ebola Viruses (2001) (230)
- The ecology of Ebola virus. (2007) (226)
- Filoviridae: Marburg and ebola viruses (2013) (225)
- Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates (2013) (223)
- Appendix Table 2 (2007) (220)
- A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates (2015) (218)
- Lethal Influenza Virus Infection in Macaques Is Associated with Early Dysregulation of Inflammatory Related Genes (2009) (215)
- Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. (2011) (215)
- Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset (2014) (210)
- Molecular Determinants of Ebola Virus Virulence in Mice (2006) (202)
- Reverse Genetics Demonstrates that Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Essential for Replication in Cell Culture (2002) (201)
- Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. (1993) (195)
- Antibody-Dependent Enhancement of Ebola Virus Infection (2003) (192)
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. (2008) (191)
- Severe Acute Respiratory Syndrome-Related Coronavirus Is Inhibited by Interferon-α (2004) (191)
- Viral hemorrhagic fever – a vascular disease? (2003) (190)
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates (2008) (189)
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain (2015) (188)
- Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. (2011) (188)
- Effects of Ebola Virus Glycoproteins on Endothelial Cell Activation and Barrier Function (2005) (183)
- The Pathogenesis of Ebola Virus Disease. (2017) (178)
- Identification of a new North American hantavirus that causes acute pulmonary insufficiency. (1995) (177)
- Ebola virus: unravelling pathogenesis to combat a deadly disease. (2006) (176)
- Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment (2006) (176)
- Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool (2016) (169)
- Assembly and Budding of Ebolavirus (2006) (168)
- Genome structure and variability of a virus causing hantavirus pulmonary syndrome. (1994) (164)
- Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. (1994) (164)
- Inclusion Bodies Are a Site of Ebolavirus Replication (2012) (158)
- A New Ebola Virus Nonstructural Glycoprotein Expressed through RNA Editing (2011) (157)
- Disease modeling for Ebola and Marburg viruses (2009) (157)
- Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge (2019) (156)
- Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. (1992) (154)
- A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana (1995) (153)
- Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice (2008) (150)
- Molecular biology and evolution of filoviruses. (1993) (149)
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates (2008) (147)
- Ebola virus vaccines: an overview of current approaches (2014) (144)
- Pneumonia from human coronavirus in a macaque model. (2013) (144)
- Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. (2006) (144)
- Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses (2009) (142)
- Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates (2012) (142)
- Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. (2006) (140)
- An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (2020) (137)
- Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever (2012) (135)
- A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge (2011) (134)
- Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. (2011) (134)
- Identification of Cell Surface Molecules Involved in Dystroglycan-Independent Lassa Virus Cell Entry (2011) (133)
- Characterization of protein–protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus (2004) (131)
- A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity (2014) (131)
- Resolution of Primary Severe Acute Respiratory Syndrome-Associated Coronavirus Infection Requires Stat1 (2004) (131)
- Production of Novel Ebola Virus-Like Particles from cDNAs: an Alternative to Ebola Virus Generation by Reverse Genetics (2004) (129)
- The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters (2013) (129)
- Rift Valley fever outbreak--Kenya, November 2006-January 2007. (2007) (129)
- Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody (2014) (125)
- Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever. (2007) (125)
- Cross-Protection against Marburg Virus Strains by Using a Live, Attenuated Recombinant Vaccine (2006) (124)
- The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. (2001) (122)
- Infection of Naïve Target Cells with Virus-Like Particles: Implications for the Function of Ebola Virus VP24 (2006) (122)
- Ebola and Marburg haemorrhagic fever. (2015) (120)
- Mutation rate and genotype variation of Ebola virus from Mali case sequences (2015) (119)
- Glycosylation and oligomerization of the spike protein of marburg virus (1991) (119)
- The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. (1999) (118)
- Characterization of the L gene and 5' trailer region of Ebola virus. (1999) (116)
- Role of Ebola Virus Secreted Glycoproteins and Virus-Like Particles in Activation of Human Macrophages (2005) (114)
- A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge (2012) (113)
- Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. (1993) (113)
- Reverse Genetics for Crimean-Congo Hemorrhagic Fever Virus (2003) (112)
- Release of viral glycoproteins during Ebola virus infection. (1998) (111)
- Biosynthesis and role of filoviral glycoproteins. (2001) (109)
- Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine (2013) (108)
- Inhibition of Nipah Virus Infection In Vivo: Targeting an Early Stage of Paramyxovirus Fusion Activation during Viral Entry (2010) (108)
- Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection (2020) (108)
- Generation of biologically contained Ebola viruses (2008) (107)
- Identification of Protective Epitopes on Ebola Virus Glycoprotein at the Single Amino Acid Level by Using Recombinant Vesicular Stomatitis Viruses (2003) (106)
- Ebola. (2020) (105)
- Ebola--a growing threat? (2014) (105)
- A Syrian golden hamster model recapitulating ebola hemorrhagic fever. (2013) (105)
- Oligomerization of Ebola Virus VP40 Is Essential for Particle Morphogenesis and Regulation of Viral Transcription (2010) (104)
- Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates (2012) (102)
- Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment. (2004) (102)
- Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus) (2011) (102)
- Proteolytic processing of Marburg virus glycoprotein. (2000) (101)
- Clinical Outcome of Henipavirus Infection in Hamsters Is Determined by the Route and Dose of Infection (2011) (100)
- Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification. (2007) (100)
- Seroepidemiological Prevalence of Multiple Species of Filoviruses in Fruit Bats (Eidolon helvum) Migrating in Africa. (2015) (99)
- The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. (1998) (99)
- Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein (2010) (99)
- A Novel Model of Lethal Hendra Virus Infection in African Green Monkeys and the Effectiveness of Ribavirin Treatment (2010) (98)
- Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection (2012) (98)
- Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection. (2015) (98)
- Lassa Fever in West Africa: Evidence for an Expanded Region of Endemicity (2012) (97)
- Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. (2013) (97)
- Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. (2011) (97)
- Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route (2012) (97)
- Enzyme-Linked Immunosorbent Assay for Detection of Filovirus Species-Specific Antibodies (2010) (96)
- Detection of Lassa Virus, Mali (2010) (96)
- Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. (2008) (96)
- Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys (2021) (95)
- Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. (2005) (95)
- A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus (2011) (94)
- Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection (2020) (94)
- Phylogeny of New World arenaviruses based on the complete coding sequences of the small genomic segment identified an evolutionary lineage produced by intrasegmental recombination. (2002) (93)
- A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses (2015) (92)
- Clinical aspects of Marburg hemorrhagic fever. (2011) (91)
- Progress in filovirus vaccine development: evaluating the potential for clinical use (2011) (91)
- Mass Spectrometric Characterization of Proteins from the SARS Virus (2003) (90)
- Rescue of Hantaan virus minigenomes. (2003) (90)
- Protective efficacy of neutralizing antibodies against Ebola virus infection. (2007) (89)
- Sequence analysis of the Marburg virus nucleoprotein gene: comparison to Ebola virus and other non-segmented negative-strand RNA viruses. (1992) (89)
- Therapeutic strategies to target the Ebola virus life cycle (2019) (89)
- Gamma Irradiation as an Effective Method for Inactivation of Emerging Viral Pathogens. (2019) (88)
- The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials (2018) (88)
- Pandemic Swine-Origin H1N1 Influenza A Virus Isolates Show Heterogeneous Virulence in Macaques (2010) (88)
- Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus. (2011) (88)
- Post-exposure treatments for Ebola and Marburg virus infections (2018) (87)
- Current ebola vaccines (2012) (87)
- The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo (2012) (86)
- Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine (2009) (86)
- The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified. (2009) (86)
- The nucleotide sequence of the L gene of Marburg virus, a filovirus: homologies with paramyxoviruses and rhabdoviruses. (1992) (85)
- Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus (2013) (84)
- Replication-Deficient Ebolavirus as a Vaccine Candidate (2009) (84)
- Immunobiology of Ebola and Lassa virus infections (2017) (83)
- Postexposure Treatment of Marburg Virus Infection (2010) (83)
- Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages? (1998) (83)
- Prospects for immunisation against Marburg and Ebola viruses (2010) (83)
- The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset (2015) (82)
- Molecular pathogenesis of filovirus infections: role of macrophages and endothelial cells. (1999) (82)
- Ebola Virus VP40 Late Domains Are Not Essential for Viral Replication in Cell Culture (2005) (81)
- Discovery of an antibody for pan-ebolavirus therapy (2016) (80)
- Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein (1993) (80)
- Epitopes required for antibody-dependent enhancement of Ebola virus infection. (2007) (78)
- Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model (2021) (78)
- Ebola Virion Attachment and Entry into Human Macrophages Profoundly Effects Early Cellular Gene Expression (2011) (77)
- Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick. (2015) (77)
- An Ebola whole-virus vaccine is protective in nonhuman primates (2015) (77)
- In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. (2007) (77)
- RNA Polymerase I-Driven Minigenome System for Ebola Viruses (2005) (76)
- Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway (2008) (74)
- Animal Challenge Models of Henipavirus Infection and Pathogenesis (2012) (74)
- Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses (2015) (74)
- Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain (2015) (73)
- Carbohydrate structure of Marburg virus glycoprotein (1992) (73)
- Filoviruses as emerging pathogens (1994) (73)
- Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. (1999) (73)
- Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome (2013) (72)
- Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates (2014) (72)
- Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model (2016) (72)
- The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin (2011) (70)
- Genetic identification of a new Puumala virus strain causing severe hemorrhagic fever with renal syndrome in Germany. (1994) (70)
- Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. (2014) (69)
- Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections. (2011) (69)
- Cathepsin B & L Are Not Required for Ebola Virus Replication (2012) (69)
- Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells (2011) (69)
- An Upstream Open Reading Frame Modulates Ebola Virus Polymerase Translation and Virus Replication (2013) (68)
- Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus (2011) (67)
- A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques (2021) (66)
- Adenovirus Vectors Expressing Hantavirus Proteins Protect Hamsters against Lethal Challenge with Andes Virus (2009) (66)
- Ebola virus ecology: a continuing mystery. (2004) (66)
- Vesicular Stomatitis Virus-Based Vaccine Protects Hamsters against Lethal Challenge with Andes Virus (2011) (66)
- Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques (2014) (66)
- Emerging and reemerging of filoviruses. (1996) (65)
- Use of Favipiravir to Treat Lassa Virus Infection in Macaques (2018) (65)
- Effective Chemical Inactivation of Ebola Virus (2016) (64)
- Identification of a Novel Consensus Sequence at the Cleavage Site of the Lassa Virus Glycoprotein (2000) (64)
- Functional Analysis of the Noncoding Regions of the Uukuniemi Virus (Bunyaviridae) RNA Segments (2004) (64)
- MassTag Polymerase Chain Reaction for Differential Diagnosis of Viral Hemorrhagic Fevers (2006) (63)
- The Use of a Mobile Laboratory Unit in Support of Patient Management and Epidemiological Surveillance during the 2005 Marburg Outbreak in Angola (2011) (62)
- Hantaan Virus Infection Causes an Acute Neurological Disease That Is Fatal in Adult Laboratory Mice (2002) (62)
- Antagonism of Type I Interferon Responses by New World Hantaviruses (2010) (62)
- Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona. (2016) (62)
- Comparison of the Pathogenicity of Nipah Virus Isolates from Bangladesh and Malaysia in the Syrian Hamster (2013) (62)
- Failure to detect Borna disease virus infection in peripheral blood leukocytes from humans with psychiatric disorders. (1997) (62)
- Recent advances in research on Crimean-Congo hemorrhagic fever. (2015) (61)
- Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge. (2009) (61)
- Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection. (2007) (60)
- The nucleoprotein of Marburg virus is phosphorylated. (1994) (60)
- [Clinical management of patients and deceased during the Ebola outbreak from October to December 2003 in Republic of Congo]. (2005) (60)
- Rhabdovirus-Based Vaccine Platforms against Henipaviruses (2014) (58)
- Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets (2017) (58)
- Recent advances in understanding Crimean–Congo hemorrhagic fever virus (2018) (58)
- The Syrian hamster model of hantavirus pulmonary syndrome. (2012) (58)
- Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Critical for Ebola Virus Replication in Nonhuman Primates (2007) (58)
- Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis). (2010) (57)
- Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus (2015) (57)
- In Vitro and In Vivo Activity of Ribavirin against Andes Virus Infection (2011) (57)
- Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease. (2015) (57)
- Variation in the Glycoprotein and VP35 Genes of Marburg Virus Strains☆ (1998) (57)
- New World Hantaviruses Activate IFNλ Production in Type I IFN-Deficient Vero E6 Cells (2010) (57)
- Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection (2016) (57)
- Antibody-dependent enhancement of Marburg virus infection. (2011) (56)
- Inhibition of Marburg Virus Budding by Nonneutralizing Antibodies to the Envelope Glycoprotein (2012) (56)
- An animal model for the tickborne flavivirus--Omsk hemorrhagic fever virus. (2005) (56)
- A VSV-based Zika virus vaccine protects mice from lethal challenge (2018) (56)
- Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins (2005) (55)
- Hemorrhagic Fever Viruses as Biological Weapons (2009) (55)
- Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice. (2007) (55)
- Nipah Virus Transmission in a Hamster Model (2011) (54)
- Lack of Protection Against Ebola Virus from Chloroquine in Mice and Hamsters (2015) (54)
- Foodborne Transmission of Nipah Virus in Syrian Hamsters (2014) (53)
- Ebola Virus RNA Editing Depends on the Primary Editing Site Sequence and an Upstream Secondary Structure (2013) (53)
- Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient. (2007) (53)
- A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose. (2015) (53)
- Ebola sGP—The first viral glycoprotein shown to be C-mannosylated (2007) (52)
- A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals. (2013) (52)
- Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model (2020) (52)
- Ebola vaccine trials: progress in vaccine safety and immunogenicity (2019) (52)
- Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models. (2018) (51)
- Generation of an adenoviral vaccine vector based on simian adenovirus 21. (2006) (51)
- Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection. (2011) (51)
- Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? (1992) (50)
- Vaccines for viral hemorrhagic fevers--progress and shortcomings. (2013) (50)
- Lymphopenia Associated with Highly Virulent H5N1 Virus Infection Due to Plasmacytoid Dendritic Cell–Mediated Apoptosis of T Cells (2014) (50)
- Ebola Virus Modulates Transforming Growth Factor β Signaling and Cellular Markers of Mesenchyme-Like Transition in Hepatocytes (2014) (49)
- Role for a cortical input to hippocampal area CA 1 in the consolidation of a long-termmemory (2004) (49)
- Ebola and Marburg viruses: pathogenesis and development of countermeasures. (2005) (48)
- Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus. (2011) (48)
- Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens. (2007) (48)
- Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients. (2016) (47)
- Analysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virus. (2003) (47)
- A cynomolgus macaque model for Crimean–Congo haemorrhagic fever (2018) (47)
- Rapid Molecular Strategy for Filovirus Detection and Characterization (2006) (47)
- Geographic Distribution and Genetic Characterization of Lassa Virus in Sub-Saharan Mali (2013) (47)
- 1918 H1N1 Influenza Virus Replicates and Induces Proinflammatory Cytokine Responses in Extrarespiratory Tissues of Ferrets (2018) (46)
- Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody (2013) (46)
- Modeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomes. (2014) (46)
- Filoviruses: Ecology, Molecular Biology, and Evolution. (2018) (46)
- Susceptibility of swine cells and domestic pigs to SARS-CoV-2 (2020) (46)
- A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques. (2013) (46)
- New insights into the evolutionary relationships between arenaviruses provided by comparative analysis of small and large segment sequences. (2003) (45)
- Different Potential of C-Type Lectin-Mediated Entry between Marburg Virus Strains (2010) (45)
- Henipavirus Pathogenesis in Human Respiratory Epithelial Cells (2013) (44)
- Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus (2015) (43)
- Personal Protective Equipment for Filovirus Epidemics: A Call for Better Evidence (2015) (43)
- The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster (2013) (43)
- Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection. (2007) (43)
- Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques (2018) (43)
- Molecular characterization of an isolate from the 1989/90 epizootic of Ebola virus Reston among macaques imported into the United States. (2002) (42)
- Cells Expressing the RING Finger Z Protein Are Resistant to Arenavirus Infection (2004) (42)
- Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge (2018) (42)
- 2009 pandemic H1N1 influenza virus elicits similar clinical course but differential host transcriptional response in mouse, macaque, and swine infection models (2012) (42)
- Functional Genomics Reveals the Induction of Inflammatory Response and Metalloproteinase Gene Expression during Lethal Ebola Virus Infection (2011) (42)
- Favipiravir (T‐705) but not ribavirin is effective against two distinct strains of Crimean‐Congo hemorrhagic fever virus in mice (2018) (41)
- A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques (2021) (41)
- Susceptibility of swine cells and domestic pigs to SARS-CoV-2 (2020) (41)
- Therapy and prophylaxis of Ebola virus infections. (2005) (41)
- Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients (2020) (41)
- Pause on avian flu transmission research. (2012) (41)
- Dromedary camels in northern Mali have high seropositivity to MERS-CoV (2017) (40)
- Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus (2004) (40)
- Viral hemorrhagic fevers: advancing the level of treatment (2012) (40)
- Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein. (2013) (39)
- A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle (2018) (39)
- Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2 (2020) (39)
- Ebola: Lessons on Vaccine Development. (2018) (38)
- Emerging and re-emerging infectious diseases (2002) (38)
- Chikungunya Virus Infection, Brazzaville, Republic of Congo, 2011 (2013) (38)
- Myxomavirus-Derived Serpin Prolongs Survival and Reduces Inflammation and Hemorrhage in an Unrelated Lethal Mouse Viral Infection (2013) (38)
- The structure of serotype H10 hemagglutinin of influenza A virus: comparison of an apathogenic avian and a mammalian strain pathogenic for mink. (1988) (37)
- Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene. (2011) (37)
- Transmission Studies Resume for Avian Flu (2013) (37)
- Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry. (2010) (37)
- Reverse genetics systems as tools for the development of novel therapies against filoviruses (2014) (37)
- Development and Evaluation of a Simple Assay for Marburg Virus Detection Using a Reverse Transcription-Loop-Mediated Isothermal Amplification Method (2010) (37)
- Potent Vesicular Stomatitis Virus-Based Avian Influenza Vaccines Provide Long-Term Sterilizing Immunity against Heterologous Challenge (2010) (36)
- Animal models for highly pathogenic emerging viruses (2013) (36)
- A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge (2018) (36)
- An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity (2016) (35)
- Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola. (2010) (35)
- Ebola and Marburg viruses : molecular and cellular biology (2004) (35)
- Transmission of henipaviruses. (2018) (34)
- Flexibility of Mobile Laboratory Unit in Support of Patient Management During the 2007 Ebola‐Zaire Outbreak in the Democratic Republic of Congo (2012) (34)
- Rescue of Ebola virus from cDNA using heterologous support proteins. (2004) (34)
- Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus. (2003) (34)
- Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995. (1999) (34)
- Framework for Leadership and Training of Biosafety Level 4 Laboratory Workers (2008) (33)
- Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models (2020) (33)
- Viral haemorrhagic fever and vascular alterations. (2008) (33)
- Truly emerging--a new disease caused by a novel virus. (2011) (33)
- Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo (2018) (32)
- Virus in Semen and the Risk of Sexual Transmission. (2018) (32)
- A Comparative Review of Animal Models of Middle East Respiratory Syndrome Coronavirus Infection (2016) (32)
- Pause on Avian Flu Transmission Research (2012) (32)
- Progress towards the treatment of Ebola haemorrhagic fever (2006) (32)
- Filoviruses and Arenaviruses (2006) (32)
- Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation (2019) (31)
- Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. (1998) (31)
- C-type lectins do not act as functional receptors for filovirus entry into cells. (2010) (31)
- Ebola virus vaccines – reality or fiction? (2016) (30)
- Molecular characterization of Borna disease virus from naturally infected animals and possible links to human disorders. (1997) (30)
- A new Clethrionomys-derived hantavirus from Germany: evidence for distinct genetic sublineages of Puumala viruses in Western Europe. (1999) (30)
- A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades (2020) (29)
- Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection (2015) (29)
- Emergence of subtype Zaire Ebola virus in Gabon. (1997) (29)
- Experimental Andes Virus Infection in Deer Mice: Characteristics of Infection and Clearance in a Heterologous Rodent Host (2013) (29)
- Hamster-Adapted Sin Nombre Virus Causes Disseminated Infection and Efficiently Replicates in Pulmonary Endothelial Cells without Signs of Disease (2013) (29)
- Syrian Hamsters (Mesocricetus auratus) Oronasally Inoculated With a Nipah Virus Isolate From Bangladesh or Malaysia Develop Similar Respiratory Tract Lesions (2015) (29)
- African Green Monkeys Recapitulate the Clinical Experience with Replication of Live Attenuated Pandemic Influenza Virus Vaccine Candidates (2014) (29)
- Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs (2015) (28)
- Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death (2019) (28)
- Differential Innate Immune Responses Elicited by Nipah Virus and Cedar Virus Correlate with Disparate In Vivo Pathogenesis in Hamsters (2019) (28)
- Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge (2019) (28)
- Preparing a Community Hospital to Manage Work-related Exposures to Infectious Agents in BioSafety Level 3 and 4 Laboratories (2010) (27)
- An Antibody Directed against the Fusion Peptide of Junín Virus Envelope Glycoprotein GPC Inhibits pH-Induced Membrane Fusion (2010) (27)
- Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali (2016) (27)
- Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection (2019) (26)
- Rapid detection of Lassa virus by reverse transcription‐loop‐mediated isothermal amplification (2011) (26)
- Sequencing, Annotation and Analysis of the Syrian Hamster (Mesocricetus auratus) Transcriptome (2014) (26)
- Immune Response to Marburg Virus Angola Infection in Nonhuman Primates. (2015) (26)
- A DNA-based vaccine protects against Crimean-Congo hemorrhagic fever virus disease in a Cynomolgus macaque model (2020) (26)
- Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection (2017) (26)
- Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies (2011) (26)
- Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates (2020) (26)
- Comparative Pathogenesis of Three Human and Zoonotic SARS-CoV Strains in Cynomolgus Macaques (2011) (26)
- Complete Genome Sequences of Three Ebola Virus Isolates from the 2014 Outbreak in West Africa (2014) (26)
- The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak (2016) (25)
- Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine (2022) (25)
- Inactivation of SARS-CoV-2 Laboratory Specimens (2021) (25)
- A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever (2016) (25)
- Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver (2017) (24)
- Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets (2018) (24)
- Marburg hemorrhagic fever--the forgotten cousin strikes. (2006) (24)
- Truncated Hantavirus Nucleocapsid Proteins for Serotyping Sin Nombre, Andes, and Laguna Negra Hantavirus Infections in Humans and Rodents (2010) (23)
- Transcriptional Correlates of Tolerance and Lethality in Mice Predict Ebola Virus Disease Patient Outcomes. (2020) (23)
- Indirect Immunofluorescence Assay for the Simultaneous Detection of Antibodies against Clinically Important Old and New World Hantaviruses (2013) (23)
- Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques (2021) (22)
- Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015. (2016) (22)
- Biosafety Level-4 Laboratories in Europe: Opportunities for Public Health, Diagnostics, and Research (2013) (22)
- Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis (2020) (22)
- Next-Generation Sequencing Reveals a Controlled Immune Response to Zaire Ebola Virus Challenge in Cynomolgus Macaques Immunized with Vesicular Stomatitis Virus Expressing Zaire Ebola Virus Glycoprotein (VSVΔG/EBOVgp) (2015) (21)
- Influenza Virus A/Anhui/1/2013 (H7N9) Replicates Efficiently in the Upper and Lower Respiratory Tracts of Cynomolgus Macaques (2014) (21)
- Polymorphism of filovirus glycoproteins. (2005) (21)
- Differential Lymphocyte and Antibody Responses in Deer Mice Infected with Sin Nombre Hantavirus or Andes Hantavirus (2014) (20)
- Expression profiling of lymph node cells from deer mice infected with Andes virus (2013) (20)
- The role of reverse genetics systems in studying viral hemorrhagic fevers (2005) (20)
- Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines. (2015) (20)
- Fcγ-receptor IIa-mediated Src Signaling Pathway Is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection (2016) (20)
- Assessing the contribution of interferon antagonism to the virulence of West African Ebola viruses (2015) (20)
- Establishment of conventional and fluorescence resonance energy transfer-based real-time PCR assays for detection of pathogenic New World arenaviruses. (2005) (20)
- Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model (2020) (20)
- Seasonal H3N2 influenza A virus fails to enhance Staphylococcus aureus co-infection in a non-human primate respiratory tract infection model (2013) (20)
- Peri-exposure protection against Nipah virus disease using a single-dose recombinant vesicular stomatitis virus-based vaccine (2016) (20)
- Ebolavirus in West Africa, and the use of experimental therapies or vaccines (2014) (19)
- Assessment of rodents as animal models for Reston ebolavirus. (2011) (19)
- Vectorborne Infections, Mali (2016) (19)
- Serosurvey of Crimean-Congo Hemorrhagic Fever Virus in Cattle, Mali, West Africa. (2017) (19)
- Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment. (2016) (19)
- Identifying Early Target Cells of Nipah Virus Infection in Syrian Hamsters (2016) (19)
- The immune response to Nipah virus infection (2012) (19)
- Long-Term Single-Dose Efficacy of a Vesicular Stomatitis Virus-Based Andes Virus Vaccine in Syrian Hamsters (2014) (19)
- Domestic Pig Unlikely Reservoir for MERS-CoV (2017) (19)
- Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out Mice (2018) (18)
- Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles. (2011) (18)
- A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins (2021) (18)
- Polymerase chain reaction detection of Puumala virus RNA in formaldehyde-fixed biopsy material. (1999) (18)
- Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses. (2016) (18)
- Possible leap ahead in filovirus therapeutics (2014) (18)
- Niemann-Pick C1 Heterogeneity of Bat Cells Controls Filovirus Tropism. (2020) (18)
- Recently Emerged Swine Influenza A Virus (H2N3) Causes Severe Pneumonia in Cynomolgus Macaques (2012) (18)
- Are we any closer to combating Ebola infections? (2010) (17)
- Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure. (2013) (17)
- Lifecycle modelling systems support inosine monophosphate dehydrogenase (IMPDH) as a pro‐viral factor and antiviral target for New World arenaviruses (2018) (16)
- Cluster of cases of hantavirus pulmonary syndrome in Alberta, Canada. (2007) (16)
- Animal Models of Tick-Borne Hemorrhagic Fever Viruses (2013) (16)
- Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection. (2015) (16)
- Development of a minigenome system for Andes virus, a New World hantavirus (2012) (15)
- In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics. (2007) (15)
- Unique Strain of Crimean–Congo Hemorrhagic Fever Virus, Mali (2014) (15)
- SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern (2022) (15)
- Single-Nucleotide Polymorphisms in Human NPC1 Influence Filovirus Entry Into Cells. (2018) (15)
- Filoviruses: recent advances and future challenges. (2007) (15)
- Differential expression of the Ebola virus GP(1,2) protein and its fragments in E. coli. (2007) (15)
- REVERSE GENETICS FOR CRIMEANCONGO HEMORRHAGIC FEVER VIRUS (2003) (14)
- Laguna Negra Virus Infection Causes Hantavirus Pulmonary Syndrome in Turkish Hamsters (Mesocricetus brandti) (2016) (14)
- Pathogenicity of Ebola and Marburg Viruses Is Associated With Differential Activation of the Myeloid Compartment in Humanized Triple Knockout-Bone Marrow, Liver, and Thymus Mice. (2018) (14)
- Lassa Virus Treatment Options (2021) (14)
- Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. (2015) (14)
- Amending Koch's postulates for viral disease: When “growth in pure culture” leads to a loss of virulence (2016) (14)
- Human immune system mouse models of Ebola virus infection. (2017) (14)
- Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence (2019) (14)
- Ebola: facing a new transboundary animal disease? (2013) (13)
- Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species (2015) (13)
- Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in COPD. (2020) (13)
- Kyasanur Forest Disease and Alkhurma Hemorrhagic Fever Virus—Two Neglected Zoonotic Pathogens (2020) (13)
- Targeting Ebola virus replication through pharmaceutical intervention (2021) (13)
- Ebola Virus Infection in Commonly Used Laboratory Mouse Strains. (2018) (13)
- The Crux of Ebola Diagnostics. (2017) (12)
- Breakdown of paraendothelial barrier function during Marburg virus infection is associated with early tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1. (2007) (12)
- Laboratory Response to 2014 Ebola Virus Outbreak in Mali. (2016) (12)
- A synthetic consensus anti-Spike protein DNA vaccine induces protective immunity against Middle East Respiratory Syndrome Coronavirus in non-human primates (2016) (12)
- Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge. (2019) (12)
- Old World hantaviruses in rodents in New Orleans, Louisiana. (2014) (12)
- A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades. (2020) (12)
- Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus (2020) (12)
- Annual Incidence of Lassa Virus Infection in Southern Mali. (2017) (12)
- Hemorrhagic Fever with Renal Syndrome: Diagnostic Problems with a Known Disease (2001) (12)
- The role of reverse genetics systems in determining filovirus pathogenicity. (2005) (11)
- Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques. (2020) (11)
- Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model (2022) (11)
- Delineating Ebola entry (2015) (11)
- Importin-α7 Is Involved in the Formation of Ebola Virus Inclusion Bodies but Is Not Essential for Pathogenicity in Mice. (2015) (11)
- Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers (2020) (11)
- Symposium on Marburg and Ebola viruses. (2001) (11)
- Differential Ability of Pandemic and Seasonal H1N1 Influenza A Viruses To Alter the Function of Human Neutrophils (2018) (10)
- Ebola and Marburg (2009) (10)
- Histologic pulmonary lesions of SARS-CoV-2 in 4 nonhuman primate species: An institutional comparative review (2021) (10)
- Delayed Inflammatory and Cell Death Responses Are Associated with Reduced Pathogenicity in Lujo Virus-Infected Cynomolgus Macaques (2014) (10)
- Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice (2015) (10)
- Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model (2019) (9)
- Human Polyclonal Antibodies Produced by Transchromosomal Cattle Provide Partial Protection Against Lethal Zaire Ebolavirus Challenge in Rhesus Macaques. (2018) (9)
- The Ebola virus soluble glycoprotein (sGP) does not affect lymphocyte apoptosis and adhesion to activated endothelium. (2011) (9)
- SARS-CoV-2 infection dynamics in lungs of African green monkeys (2020) (9)
- UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates (2021) (9)
- Purification of Crimean–Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis (2021) (9)
- Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo (2015) (9)
- UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates (2021) (9)
- Reston virus causes severe respiratory disease in young domestic pigs (2020) (9)
- Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody Responses. (2015) (9)
- Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease (2022) (9)
- Enhanced detection of Rift Valley fever virus using molecular assays on whole blood samples. (2012) (9)
- 6th International Conference on Emerging Zoonoses (2012) (8)
- Monoclonal Antibody Cocktail Protects Hamsters From Lethal Marburg Virus Infection. (2018) (8)
- Erratum to “Sequence determination of the Crimean–Congo hemorrhagic fever virus L segment” [Virology 321 (2004) 23–28] (2004) (8)
- The structure of serotype H10 hemagglutinin of influenza a virus: Comparison of an apathogenic avian and a mammalian strain pathogenic for mink (1988) (8)
- Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment (2020) (8)
- Clinical Chemistry of Patients With Ebola in Monrovia, Liberia. (2016) (8)
- Reverse Genetics Systems for Filoviruses. (2017) (8)
- An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters (2021) (7)
- SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta (2022) (7)
- Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset (2019) (7)
- Blockage of filoviral glycoprotein processing by use of a protein-based inhibitor. (2007) (7)
- Novel neutralizing monoclonal antibodies protect rodents against lethal filovirus challenges (2014) (7)
- SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract (2022) (7)
- Evaluation of drugs for Potential Repurposing against COVID-19 using a Tier-Based Scoring System (2020) (7)
- Establishment of a Genetically Confirmed Breeding Colony of Mastomys natalensis from Wild-Caught Founders from West Africa (2021) (7)
- Humanized Mice--A Neoteric Animal Disease Model for Ebola Virus? (2016) (6)
- Broad-spectrum Investigational Agent GS-5734 for the Treatment of Ebola, MERS Coronavirus and Other Pathogenic Viral Infections with High Outbreak Potential (2017) (6)
- Potential Impact of a 2-Person Security Rule on BioSafety Level 4 Laboratory Workers (2009) (6)
- Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus (2021) (6)
- Ebolavirus: An Overview of Molecular and Clinical Pathogenesis. (2017) (6)
- The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway (2021) (6)
- Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge (2022) (6)
- Two strings to the bow of Ebola virus (1998) (6)
- Trend of Crimean-Congo Hemorrhagic Fever (CCHF) in Iran in Recent Years (2008) (5)
- MARBURG AND EBOLA VIRUSES (FILOVIRIDAE) (1999) (5)
- Animal models for Lassa virus infection. (2019) (5)
- Host Competency of the Multimammate Rat Mastomys natalensis Demonstrated by Prolonged Spirochetemias with the African Relapsing Fever Spirochete Borrelia crocidurae. (2019) (5)
- Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model (2022) (5)
- Utility of primary cells to examine NPC1 receptor expression in Mops condylurus, a potential Ebola virus reservoir (2020) (5)
- Emerging Zoonoses: Recent Advances and Future Challenges (2009) (5)
- Ebola Virus Glycoprotein Domains Associated with Protective Efficacy (2021) (5)
- Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques (2021) (5)
- Genetic Identificationo f a HantavirusA ssociated with an Outbreako f Acute RespiratoryI llness (1993) (4)
- Severe Fever with Thrombocytopenia Syndrome Associated with a Novel Bunyavirus (2014) (4)
- Seroprevalence of Rift Valley Fever Virus Antibodies in Cattle in Mali, 2005-2014. (2018) (4)
- Lack of evidence for an association between hantavirus infections and Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and giant cell arteritis. (2000) (4)
- Dendritic Cells Generated From Mops condylurus, a Likely Filovirus Reservoir Host, Are Susceptible to and Activated by Zaire Ebolavirus Infection (2019) (4)
- Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques. (2018) (4)
- T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice (2021) (4)
- Post-exposure treatments for Ebola and Marburg virus infections. (2018) (4)
- Coxsackievirus A 16 Encephalitis during Obinutuzumab Therapy , Belgium , 2013 (2019) (4)
- 53 – Arenaviruses and filoviruses: Viral haemorrhagic fevers (2012) (3)
- Development of a nonhuman primate model for mammalian bornavirus infection (2022) (3)
- A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle (2018) (3)
- Birth and pathogenesis of rogue respiratory viruses. (2015) (3)
- High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission (2021) (3)
- A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection. (2020) (3)
- SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern (2021) (3)
- Changing Realities in Emerging Zoonoses (2012) (3)
- The Effect of Plasmodium on the Outcome of Ebola Virus Infection in a Mouse Model. (2018) (3)
- Filoviruses (Marburg Virus and Ebola Virus), Infection and Immunity (1998) (2)
- Ebola Conquers West Africa — More to Come? (2014) (2)
- Ebola virus vaccines: an overview of current (2014) (2)
- Response to Comment on “Mutation rate and genotype variation of Ebola virus from Mali case sequences” (2016) (2)
- Bacillus paranthracis Isolate from Blood of Fatal Ebola Virus Disease Case (2020) (2)
- Nipah Virus Efficiently Replicates in Human Smooth Muscle Cells without Cytopathic Effect (2021) (2)
- Hantavirus Cardiopulmonary Syndrome in Canada (2020) (2)
- Mastomys natalensis Has a Cellular Immune Response Profile Distinct from Laboratory Mice (2021) (2)
- Temporal analysis of Lassa virus infection and transmission in experimentally infected Mastomys natalensis. (2022) (2)
- CHAPTER 73 – Filovirus Infections (2011) (2)
- Oseltamivir Is Effective against 1918 Influenza Virus Infection of Macaques but Vulnerable to Escape (2019) (2)
- Combined Molnupiravir and Nirmatrelvir Treatment Improves the Inhibitory Effect on SARS-CoV-2 in Rhesus Macaques (2022) (2)
- Favipiravir (T-705) Protects IFNAR−/− Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner (2021) (2)
- Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters (2021) (2)
- Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino-oligomers (2020) (2)
- 206 Transcriptional signatures of pathogenesis and successful type I interferon and ribavirin therapy in a rhesus macaque model of MERS-CoV infection (2013) (2)
- A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus (2021) (1)
- Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment (2021) (1)
- Recombinant Ebolavirus antigens from insect cells are potent immunogens inducing cellular and humoral immunity in rodents and non-human primates and provide protection against virus challenge (P4325) (2013) (1)
- VSV-based vaccine provides species-specific protection against Sudan virus challenge in macaques (2022) (1)
- 141. Adenovirus Vaccine to Ebola Virus: Mechanism of Protection and Impact of Pre-Existing Immunity to the Vaccine Carrier (2005) (1)
- Modern dosimetric tools for 60Co irradiation at high containment laboratories (2011) (1)
- Multiple DNA viruses identified in multimammate mouse (Mastomys natalensis) populations from across regions of sub-Saharan Africa (2020) (1)
- Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque infection model. (2022) (1)
- Endothelial Biomedicine: Hemorrhagic Fevers: Endothelial Cells and Ebola-Virus Hemorrhagic Fever (2007) (1)
- 2009 pandemic H1N1 influenza virus elicits similar clinical course but differential host transcriptional response in mouse, macaque, and swine infection models (2012) (1)
- A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned (2022) (1)
- A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge (2018) (1)
- New challenges to health: Structure and function of the proteins of Marburg and Ebola viruses (2001) (1)
- Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques (2023) (1)
- SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta (2022) (1)
- Correction: Indirect Immunofluorescence Assay for the Simultaneous Detection of Antibodies against Clinically Important Old and New World Hantaviruses (2020) (1)
- Biomarkers for Lassa fever outcome (2018) (1)
- Ebolavirus in West Africa, and the use of experimental therapies or vaccines (2014) (1)
- Ebola Virus Modulates Transforming Growth Factor-β Signaling and Cellular Markers of 1 (2014) (1)
- Alkhurma haemorrhagic fever virus causes lethal disease in IFNAR-/- mice (2021) (1)
- Postexposure Treatment of (2010) (1)
- Ebola virus is unlikely to become endemic in West Africa (2016) (1)
- Responses to Ebola and Marburg virus infections (2009) (1)
- Marburg and Ebola Haemorrhagic Fevers (2003) (1)
- The immune response to Nipah virus infection (2012) (0)
- Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational study (2022) (0)
- A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned (2023) (0)
- A cynomolgus macaque model for Crimean–Congo haemorrhagic fever (2018) (0)
- Expression profiling of lymph node cells from deer mice infected with Andes virus (2013) (0)
- Running title : Gene expression in Lujo and Lassa-infected macaques 4 5 (2014) (0)
- Ebola Virus IgG Seroprevalence in Southern Mali (2021) (0)
- Faculty Opinions recommendation of Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. (2018) (0)
- Dedication: Jim Orzechowski (1944–2003) and Michael Kiley (1942–2004) (2007) (0)
- Faculty Opinions recommendation of Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection. (2018) (0)
- Prospects for immu and Ebola viruses (2010) (0)
- Recombinant vesicular stomatitis viruses as imports against viral hemorrhagic fever (2003) (0)
- Author response: Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus (2021) (0)
- Faculty Opinions recommendation of The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. (2018) (0)
- P014 Ebola virus induces a differential cytokine response and NFKB activation in infected cells (2012) (0)
- Prior vaccination with the rVSV-ZEBOV vaccine does not interfere with but improves the efficacy of postexposure antibody treatment in nonhuman primates exposed to Ebola virus (2020) (0)
- Single-dose treatment with VSV-EBOV expressing Ebola virus-specific artificial miRNAs does not protect mice from lethal disease (2023) (0)
- Faculty Opinions recommendation of Crimean-Congo Hemorrhagic Fever Virus Suppresses Innate Immune Responses via a Ubiquitin and ISG15 Specific Protease. (2018) (0)
- Methanol Fixation, but not Giemsa Staining, Inactivates Ebola and Lassa Viruses in Peripheral Blood Smears Made on Plastic Microscope Slides. (2020) (0)
- Faculty Opinions recommendation of Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice. (2018) (0)
- Dedication: Jim Orzechowski (1944–2003) and Michael Kiley (1942–2004) (2007) (0)
- The VSVΔG/ZEBOV GP vaccine protects against an Ebola infection and induces humoral and cellular immunity (128.16) (2009) (0)
- 2311. Bacteremia Is Not Commonly Detected in Ebola Virus Disease (2019) (0)
- Professor Dr. Hans-Dieter Klenk (1938–2021) (2021) (0)
- Faculty Opinions recommendation of Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection. (2018) (0)
- A VSV-based Zika virus vaccine protects mice from lethal challenge (2018) (0)
- Endothelial activation and change of barrier function by soluble Ebola virus glycoproteins (2004) (0)
- Marburg-like viruses (2002) (0)
- Marburg and Ebola Viruses – Marking 50 Years Since Their Discovery (2018) (0)
- 373. Simian Adenoviral Vector Based-Vaccine Fully Protect Against Ebola Virus Even in the Presence of Pre-Existing Immunity to Human Adenovirus (2004) (0)
- Chapter 70 – Filovirus Infections (2006) (0)
- Faculty Opinions recommendation of Biochemical and Structural Insights into the Preference of Nairoviral DeISGylases for Interferon-Stimulated Gene Product 15 Originating from Certain Species. (2018) (0)
- 206 (2013) (0)
- Hematologic and serum biochemistry reference intervals using defined ASCVP methodology for laboratory natal multimammate mice (Mastomys natalensis) (2021) (0)
- Reply to Colebunders. (2017) (0)
- Expression Strategy and Functions of the Filoviral Glycoproteins (2002) (0)
- 368. Pseudotyping HIV Vector with the Spike Envelope Protein of SARS-CoV for Studying Viral Tropism, Immunology and Gene Therapy Applications (2004) (0)
- Faculty Opinions recommendation of The role of ticks in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus: A review of published field and laboratory studies. (2018) (0)
- 604. Comparative Analysis of Different Methods for Quantitative Evaluation of Neutralizing Antibody to Ebola Virus in a Biosafety Level 2 or 4 Environment (2006) (0)
- Faculty Opinions recommendation of Transstadial Transmission and Long-term Association of Crimean-Congo Hemorrhagic Fever Virus in Ticks Shapes Genome Plasticity. (2018) (0)
- Faculty Opinions recommendation of Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic and Wild Animals. (2018) (0)
- 595. Nasal Delivery of Adenovirus Expressing the Ebola Glycoprotein Protects Mice Against Ebola Virus in the Presence of Preexisting Immunity to the Vaccine Carrier (2006) (0)
- Correction to: Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model (2019) (0)
- The variety of study in the field of emerging viruses. (2012) (0)
- Meeting review: 6th International Conference on Emerging Zoonoses (2013) (0)
- Rapid CommunicationRescue of Hantaan virus minigenomes (2003) (0)
- Title : Multiple DNA viruses identified in multimammate mouse ( Mastomys natalensis ) populations from across regions of Sub-Saharan Africa (2020) (0)
- Identification of a Novel Consensus Sequence at the Cleavage Site of the Lassa Virus Glycoprotein (2001) (0)
- P1047 The situation of Crimean-Congo haemorrhagic fever in the last years in Iran (2007) (0)
- VSVΔG MARV GP and VSVΔG ZEBOV GP induce strong and rapid anti-viral state in mouse peritoneal macrophages through type I interferon stimulation (128.11) (2009) (0)
- 1 Outbreaks of Ebolavirus Hemorrhagic Fever Virus Year ( s ) Location Cases ( % Case Fatality ) Epidemiology Remarks (2014) (0)
- Three-Week Old Pigs Are Not Susceptible to Productive Infection with SARS-COV-2 (2022) (0)
- Anti-Ebola GP monoclonal antibodies protect mice and guinea pigs against lethal ebola virus challenge (105.29) (2011) (0)
- Coronavirus The Genome Sequence of the SARS-Associated (2010) (0)
- Ebola Virus Matrix VP40 Protein Uses the COPII Transport System for Its Intracellular Transport (2008) (0)
- Species-specific MARCO-alphavirus interactions dictate chikungunya virus viremia. (2023) (0)
- Myxomavirus-derived serpin prolongs survival and reduces vasculitis in lethal herpesviral infection in mice by modulating thrombotic factor X and inflammatory cytokine IL-10 (2013) (0)
- Faculty Opinions recommendation of Cytokines as biomarkers of Crimean-Congo hemorrhagic fever. (2018) (0)
- RAPID COMMUNICATION Proteolytic Processing of Marburg Virus Glycoprotein (2000) (0)
- Faculty Opinions recommendation of Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus. (2018) (0)
- Faculty Opinions recommendation of Interactions of Human Dermal Dendritic Cells and Langerhans Cells Treated with Hyalomma Tick Saliva with Crimean-Congo Hemorrhagic Fever Virus. (2018) (0)
- Faculty Opinions recommendation of The Non-structural Protein of Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane Potential and Induces Apoptosis. (2018) (0)
- Vesicular Stomatitis Virus-Based Vaccine Protects Hamsters against Lethal Challenge with Andes Virus (cid:1) (2011) (0)
- Identification of essential host factors for Ebola Virus RNA synthesis using a genome-wide SIRNA screen (2018) (0)
- Faculty Opinions recommendation of Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice. (2018) (0)
- Tip Your Cap for Ebola Virus Neutralization. (2018) (0)
- 189: Differences in cytokine responses during infection with high and low pathogenic Ebola viruses (2013) (0)
- Professor Dr. Hans-Dieter Klenk (1938–2021) (2021) (0)
- PL-16 Ebola and Marburg viruses: Immunopathology and immunoprotection (2008) (0)
- DEVELOPMENT OF REPLICATION-COMPETENT VSV-BASED VACCINES FOR PROTECTION AGAINST HANTAVIRUSES (2019) (0)
- Faculty Opinions recommendation of Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. (2018) (0)
- EBOLA Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates (2012) (0)
- Faculty Opinions recommendation of Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load. (2018) (0)
- THE JOURNAL OF INFECTIOUS DISEASES (0)
- A SURVEY ON CRIMEAN–CONGO HAEMORRHAGIC FEVER BETWEEN IRANIAN CHILDREN (2008) (0)
- The VSV{Delta}G/ZEBOV GP vaccine protects against an Ebola infection and induces humoral and cellular immunity (2009) (0)
- Faculty Opinions recommendation of Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses. (2018) (0)
- pathogenicity in Lujo virus-infected cynomolgus macaques (2014) (0)
- Instructions for use Title C-type lectins do not act as functional receptors for filovirusentry into cells (2017) (0)
- 1918 H1N1 influenza virus replicates in the nervous system of ferrets (2018) (0)
- Faculty Opinions recommendation of ISG15 in antiviral immunity and beyond. (2018) (0)
- Development of arenavirus lifecycle modelling systems for screening of host cells factors involved in virus replication (2016) (0)
- Development of a minigenome system for Andes virus, a New World hantavirus (2012) (0)
- Acknowledgment of Ad Hoc Reviewers (2008) (0)
- Predominant Th2 cytokine gene expression in lymph node cell cultures from Andes virus-infected deer mice (Peromyscus maniculatus) (P6316) (2013) (0)
- A combination of DNA vaccination and a recombinant adenovirus serotype 5 boost resulted in cross-protective immunity in non-human primates. A recombinant vesicular stomatitis vaccine vector protected non-human primates (2011) (0)
- Faculty Opinions recommendation of Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection. (2018) (0)
- Laboratory diagnosis of Ebola and Marburg hemorrha (2005) (0)
- Faculty Opinions recommendation of Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus. (2018) (0)
- VSV{Delta}G MARV GP and VSV{Delta}G ZEBOV GP induce strong and rapid anti-viral state in mouse peritoneal macrophages through type I interferon stimulation (2009) (0)
- Continuing Orthohantavirus Circulation in Deer Mice in Western Montana (2021) (0)
- Chapter 8. Therapeutics Against Nipah and Hendra Virus (2021) (0)
- Editorial Board (2016) (0)
- Crimean–Congo haemorrhagic fever virus (2023) (0)
- Editorial Board (2016) (0)
- A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus (2021) (0)
- Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection (2017) (0)
- Faculty Opinions recommendation of Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers. (2018) (0)
- Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques (2022) (0)
- Therapeutic strategies to target the Ebola virus life cycle (2019) (0)
- Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model (2022) (0)
This paper list is powered by the following services:
Other Resources About Heinz Feldmann
What Schools Are Affiliated With Heinz Feldmann?
Heinz Feldmann is affiliated with the following schools:
